Suppr超能文献

用于矫正高度散光的个性化散光有晶体眼人工晶状体

Artisan toric phakic intraocular lens for the correction of high astigmatism.

作者信息

Güell Jose L, Vázquez Mercedes, Malecaze Francoise, Manero Felicidad, Gris Oscar, Velasco Fortino, Hulin Helene, Pujol Jaune

机构信息

IMO Instituto de Microcirugía Ocular, Barcelona, Spain.

出版信息

Am J Ophthalmol. 2003 Sep;136(3):442-7. doi: 10.1016/s0002-9394(03)00295-2.

Abstract

PURPOSE

To evaluate efficacy, predictability, and safety of Artisan toric phakic intraocular lens (Ophtec, Groningen, The Netherlands) implantation for the correction of astigmatism higher than 2 diopters.

DESIGN

Interventional case series.

METHODS

This prospective study included 27 eyes of 16 patients with a mean preoperative spherical equivalent of -11.78 +/- 6.24 diopters and a mean preoperative astigmatism of -3.43 +/- 0.81. The Artisan phakic intraocular lens was inserted in the anterior chamber through a posterior corneal incision; the technique is similar to the implantation of the classical Artisan lens, but in these cases it is particularly important to secure the lens accurately in the correct axis. The main parameters evaluated in this study were uncorrected visual acuity, best-corrected visual acuity, refraction, and endothelial cell count.

RESULTS

Twelve months after the implantation of the Artisan toric phakic intraocular lens, 62.90% of the eyes were within +/-0.50 diopters. of emmetropia and 96.20% within +/-1.0 diopters. Seventy percent of the eyes gained 1 or more Snellen lines from their preoperative best-corrected visual acuity, and 11.11% lost 1 Snellen line. Mean endothelial cell count increased 2.9%. Mean of the parallel and orthogonal components of cylinder correction were 1.97 diopters and 0.10 diopters, respectively, of the intended cylinder change. The mean of axis alignment error was 10.53 degrees. No serious complications were observed.

CONCLUSION

Artisan toric phakic intraocular lens implantation appears to be a safe and predictable method for the correction of high levels of astigmatism.

摘要

目的

评估Artisan有晶体眼散光人工晶状体(荷兰格罗宁根Ophtec公司)植入术矫正2屈光度以上散光的有效性、可预测性及安全性。

设计

干预性病例系列研究。

方法

本前瞻性研究纳入16例患者的27只眼,术前平均等效球镜度为-11.78±6.24屈光度,术前平均散光为-3.43±0.81。通过角膜后切口将Artisan有晶体眼人工晶状体植入前房;该技术与经典Artisan晶状体植入术相似,但在这些病例中,将晶状体准确固定在正确轴位尤为重要。本研究评估的主要参数包括裸眼视力、最佳矫正视力、验光及内皮细胞计数。

结果

Artisan有晶体眼散光人工晶状体植入术后12个月,62.90%的眼屈光不正度数在±0.50屈光度以内,96.20%在±1.0屈光度以内。70%的眼较术前最佳矫正视力提高了1行或更多Snellen视力表行数,11.11%的眼下降了1行。内皮细胞计数平均增加2.9%。柱镜矫正的平行和正交分量平均值分别为预期柱镜变化的1.97屈光度和0.10屈光度。轴位对准误差平均值为10.53度。未观察到严重并发症。

结论

Artisan有晶体眼散光人工晶状体植入术似乎是矫正高度散光的一种安全且可预测的方法。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验